Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys ; volume:8 ; number:1 ; day:10 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
npj vaccines ; 8, Heft 1 (10.11.2023), 1-12, 12.2023
- Creator
-
Boopathy, Archana V.
Sharma, Bhawna
Nekkalapudi, Anurag
Wimmer, Raphaela
Gamez-Guerrero, Maria
Suthram, Silpa
Truong, Hoa
Lee, Johnny
Li, Jiani
Martin, Ross
Blair, Wade
Geleziunas, Romas
Orlinger, Klaus
Ahmadi-Erber, Sarah
Lauterbach, Henning
Makadzange, Tariro
Falkard, Brie
Schmidt, Sarah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00768-x
- URN
-
urn:nbn:de:101:1-2024012914525595597962
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boopathy, Archana V.
- Sharma, Bhawna
- Nekkalapudi, Anurag
- Wimmer, Raphaela
- Gamez-Guerrero, Maria
- Suthram, Silpa
- Truong, Hoa
- Lee, Johnny
- Li, Jiani
- Martin, Ross
- Blair, Wade
- Geleziunas, Romas
- Orlinger, Klaus
- Ahmadi-Erber, Sarah
- Lauterbach, Henning
- Makadzange, Tariro
- Falkard, Brie
- Schmidt, Sarah
- SpringerLink (Online service)
Other Objects (12)
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model
Güterverzeichnisse Si-V
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model
Güterverzeichnisse Si-V
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
SiV
P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model